Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing ...
A 2026 informational consumer research report examining portable nebulizer technology, vibrating mesh atomization systems, respiratory comfort features, pricing transparency, and verification consider ...
Distinct COPD phenotypes show differences in severity and mortality, with worse outcomes linked to income, race, rural living, and smoking.
For people with exertional-only hypoxemia from fibrotic interstitial lung disease (ILD), use of a portable oxygen ...
The chicken produced in Costco's giant factory farming operations is the subject of new lawsuits over preservatives and safety standards.
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...
Santhera Pharmaceuticals is leveraging fresh clinical evidence to strengthen the market position of its flagship therapy, Agamree. The company recently presente ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and ...
Verily Life Sciences and Samsung Electronics America today announced a collaboration that will bring together Samsung’s ...
Most people know only two things about the appendix: You don’t need it – and if it bursts, you need surgery fast. That basic ...
Alexion, AstraZeneca Rare Disease's Koselugo (selumetinib), an oral, selective MEK inhibitor, has been approved in Canada for the treatment of adult patients with neurofibromatosis type 1 (NF1) who ...